“Members of Congress have once again raised the stakes in the GE salmon debate,” says Andrew Kimbrell, CFS executive director. “FDA simply cannot continue to ignore the growing calls to stop this misguided approval.”
The two letters were sponsored by Sen. Mark Begich (D-AK) and Rep. Don Young (R-AK) and joined by 21 members of the House and Senate. The letters remind FDA of an “ever-growing Congressional opposition” to the fish and call on the agency to shift priorities in light of the Young-Woolsey amendment that was included in the House-passed Agriculture Appropriations Act of 2012, which would bar FDA from using funds in the 2012 fiscal year to approve GE salmon, according to CFS.